2019
DOI: 10.1083/jcb.201907022
|View full text |Cite
|
Sign up to set email alerts
|

The complexity of the serine glycine one-carbon pathway in cancer

Abstract: The serine glycine and one-carbon pathway (SGOCP) is a crucially important metabolic network for tumorigenesis, of unanticipated complexity, and with implications in the clinic. Solving how this network is regulated is key to understanding the underlying mechanisms of tumor heterogeneity and therapy resistance. Here, we review its role in cancer by focusing on key enzymes with tumor-promoting functions and important products of the SGOCP that are of physiological relevance for tumorigenesis. We discuss the reg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
65
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(66 citation statements)
references
References 162 publications
1
65
0
Order By: Relevance
“…Serine hydroxymethyltransferase 2 (SHMT2), a mitochondrial SHMT, can reversibly and simultaneously catalyze the conversions of L-serine to glycine, playing significant roles in cellular one-carbon pathways [13,14]. An adequate supply of glycine is strongly responsible for rapidly proliferating cancer cells, and glycine consumption and catabolism contribute to the carcinogenesis and malignancy [15,16]. Silencing of SHMT2 is shown to be a key target for therapeutic intervention of cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Serine hydroxymethyltransferase 2 (SHMT2), a mitochondrial SHMT, can reversibly and simultaneously catalyze the conversions of L-serine to glycine, playing significant roles in cellular one-carbon pathways [13,14]. An adequate supply of glycine is strongly responsible for rapidly proliferating cancer cells, and glycine consumption and catabolism contribute to the carcinogenesis and malignancy [15,16]. Silencing of SHMT2 is shown to be a key target for therapeutic intervention of cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, other studies targeting the downstream of SSP/one-carbon metabolism are attempting to regulate the epigenetic state of the tumors and regulate the metabolic enzymes that are overactivated in the tumors (15,72,143). Epigenetic reprogramming through the regulation of the methylation pathway is essential for the malignant tumor phenotype with studies suggesting that the control of methylation is possible (144,145).…”
Section: Cancer Treatment and Potential New Opportunitiesmentioning
confidence: 99%
“…Aided by modern genomics and metabolomics tools, the roles of de novo serine synthesis and mitochondrial FOCM pathway in cancer have increasingly been appreciated ( 16 , 87 , 88 ). Given the increased requirement for nucleotides to support rapid proliferation of cancer cells, metabolism of one-carbon sources, serine and glycine, and mitochondrial folate metabolic enzymes are upregulated.…”
Section: Intracellular Compartmentalization Of One-carbon Metabolismmentioning
confidence: 99%